| abstract |
A compound of formula I; a pharmaceutical composition comprising said compound; and the use of the compound for the manufacture of a medicament for the treatment of diseases responsive to modulation of the glycine transporter, such as the positive and negative symptoms of schizophrenia, psychoses, dementia, pain, improving cognition, Alzheimer's disease, multi-infarct dementia, AIDS dementia, Huntingdon's disease, Parkinson's disease, amyotrophic lateral sclerosis or stroke. |